Pyrazinamide

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Pyrazinamide and local guidelines before prescribing.

Antimycobacterial

Mechanism

Prodrug active in acidic environments against M. tuberculosis.

Uses

Tuberculosis intensive phase.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Hepatotoxicity, hyperuricaemia and gout, arthralgia, rash.

Interactions

Allopurinol less effective; ciclosporin.

Contraindications and cautions

Acute gout, severe liver disease

Monitoring

LFT, urate

Pregnancy and breastfeeding

Acceptable

Renal and hepatic impairment

Reduce dose in renal impairment

Overdose and reversal

Supportive

Special advice

LFT baseline and regularly; uric acid.

More from the textbook: uses, cautions and other points
Where it is discussed in the book